Clinical trials in Leber hereditary optic neuropathy: outcomes and opportunities

There is increasing evidence for the potential therapeutic benefit of idebenone and lenadogene nolparvovec gene therapy.

Authors

Institutions

Publication Details

Journal
Current Opinion in Neurology
Published
2024-12-20
DOI
https://doi.org/10.1097/wco.0000000000001343
Citations
9
Primary Topic
Retinal Development and Disorders
Type
article
Field-Weighted Citation Impact
2.10
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical trials in Leber hereditary optic neuropathy: outcomes and opportunities

Nancy J. Newman, Benson S. Chen
9 citations
Current Opinion in Neurology
Retinal Development and Disorders
2.10
article

Clinical trials in Leber hereditary optic neuropathy: outcomes and opportunities

Nancy J. Newman, Benson S. Chen
article en
9 citations

Abstract

There is increasing evidence for the potential therapeutic benefit of idebenone and lenadogene nolparvovec gene therapy.

Current Opinion in NeurologyVol. 38(1)
Emory University (US), University of Auckland (NZ), University of Cambridge (GB), Addenbrooke's Hospital (GB), Neurological Surgery (US), MRC Mitochondrial Biology Unit (GB)
Good health and well-being
Openalex Percentile: Top 12%
Retinal Development and Disorders
2.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.